Frontlight ResearchEarly access
Trial site
AZ Sint-Jan Brugge-Oostende AV
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Chronic kidney disease2 trials
- High blood pressure2 trials
- Mantle cell lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting4 trials
- Completed2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- AZ Sint-Jan AV2 trials
- Medtronic Vascular2 trials
- Eli Lilly and Company1 trial
- Hemavant Sciences GmbH1 trial
- Pharmacyclics LLC.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- High blood pressure1 recruiting
- Mantle cell lymphoma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026